Literature DB >> 8807795

Natural transformation of Streptococcus crista.

F F Correia1, T L McKay, M F Farrow, B Rosan, J M DiRienzo.   

Abstract

Over the years Streptococcus gordonii (sanguis) Challis has become the workhorse of genetic manipulations for the sanguis group of oral streptococci. This is because strain Challis was shown in early studies to be highly naturally competent for transformation. However, Challis is not usually the most appropriate strain to use in studies which focus on oral microbial adherence. We report that other members of the newly reorganized sanguis group, particularly within the species S. crista, display reasonable transformation frequencies, with both plasmid and chromosomal DNA, if transformed at the appropriate time during the growth curve. The ability to transform S. crista may be especially important for genetic studies of biological properties that appear to be limited to these specific streptococcal strains.

Entities:  

Mesh:

Year:  1996        PMID: 8807795      PMCID: PMC3534804          DOI: 10.1111/j.1574-6968.1996.tb08454.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  16 in total

1.  REGULATION OF THE TRANSFORMABILITY OF PHEUMOCOCCAL CULTURES BY MACROMOLECULAR CELL PRODUCTS.

Authors:  A TOMASZ; R D HOTCHKISS
Journal:  Proc Natl Acad Sci U S A       Date:  1964-03       Impact factor: 11.205

2.  Attributes of potential utility in differentiating among "group H" streptococci or Streptococcus sanguis.

Authors:  R M Cole; G B Calandra; E Huff; K M Nugent
Journal:  J Dent Res       Date:  1976-01       Impact factor: 6.116

Review 3.  Genetic transformation in Streptococcus sanguis.

Authors:  P Gaustad
Journal:  J Oslo City Hosp       Date:  1985 Jul-Aug

4.  scbA from Streptococcus crista CC5A: an atypical member of the lraI gene family.

Authors:  F F Correia; J M DiRienzo; T L McKay; B Rosan
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

5.  Antibodies that bind to fimbriae block adhesion of Streptococcus sanguis to saliva-coated hydroxyapatite.

Authors:  S Fachon-Kalweit; B L Elder; P Fives-Taylor
Journal:  Infect Immun       Date:  1985-06       Impact factor: 3.441

6.  A cloning vector able to replicate in Escherichia coli and Streptococcus sanguis.

Authors:  F L Macrina; J A Tobian; K R Jones; R P Evans; D B Clewell
Journal:  Gene       Date:  1982-10       Impact factor: 3.688

7.  Molecular, genetic, and functional analysis of the basic replicon of pVA380-1, a plasmid of oral streptococcal origin.

Authors:  D J LeBlanc; L N Lee; A Abu-Al-Jaibat
Journal:  Plasmid       Date:  1992-09       Impact factor: 3.466

8.  Improved electroporation and cloning vector system for gram-positive bacteria.

Authors:  G M Dunny; L N Lee; D J LeBlanc
Journal:  Appl Environ Microbiol       Date:  1991-04       Impact factor: 4.792

9.  Surface structures (peritrichous fibrils and tufts of fibrils) found on Streptococcus sanguis strains may be related to their ability to coaggregate with other oral genera.

Authors:  P S Handley; P L Carter; J E Wyatt; L M Hesketh
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

10.  Transformation reactions between Pneumococcus and three strains of Streptococci.

Authors:  R M BRACCO; M R KRAUSS; A S ROE; C M MACLEOD
Journal:  J Exp Med       Date:  1957-08-01       Impact factor: 14.307

View more
  2 in total

1.  The utility of affinity-tags for detection of a streptococcal protein from a variety of streptococcal species.

Authors:  Meixian Zhou; Paula Fives-Taylor; Hui Wu
Journal:  J Microbiol Methods       Date:  2007-12-15       Impact factor: 2.363

2.  Oral microbiota species in acute apical endodontic abscesses.

Authors:  Noelle George; Erin Flamiatos; Kellie Kawasaki; Namgu Kim; Charles Carriere; Brian Phan; Raphael Joseph; Shay Strauss; Richie Kohli; Dongseok Choi; J Craig Baumgartner; Christine Sedgley; Tom Maier; Curtis A Machida
Journal:  J Oral Microbiol       Date:  2016-03-15       Impact factor: 5.474

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.